News
Nerdy (NRDY) Q2 Revenue Falls 11%
Nerdy (NYSE:NRDY), the online learning platform behind Varsity Tutors, released its second quarter results on August 7, 2025. The earnings report showed total GAAP revenue of $45.3 million, slightly
Alpha Teknova (TKNO) Q2 Revenue Jumps 7%
Alpha Teknova (NASDAQ:TKNO), a specialist in custom bioprocess solutions for the life sciences sector, released its results on August 7, 2025. The most important news: Revenue (GAAP) rose by 7%
Dorchester (DMLP) Profit Drops 56%
Dorchester Minerals (NASDAQ:DMLP), a Dallas-based owner of oil and natural gas mineral and royalty interests, reported sharply lower results. Released on August 7, 2025, the earnings revealed a
Inseego (INSG) Q2 Revenue Beats by 4%
Inseego (NASDAQ:INSG), a wireless networking provider focused on 5G and fixed wireless access technology, announced its results for the fiscal second quarter ended June 30, 2025, on Aug. 7, 2025
Skye (SKYE) Q2 R&D Soars 249% No Revenue
Skye Bioscience (NASDAQ:SKYE), a biotechnology company developing novel obesity therapeutics, released its second quarter earnings on August 7, 2025. As in prior quarters, no commercial revenue was
IN8bio (INAB) Q2 Loss Narrows 77%
IN8bio (NASDAQ:INAB), a clinical-stage biotechnology company focused on developing gamma-delta T cell therapies for cancer and autoimmune diseases, released its second quarter results on August 7
System1 (SST) Fiscal Q2 Revenue Tops 6%
System1 (NYSE:SST), a digital marketing and technology company focused on privacy-centric search, couponing, and online mapping products, released its earnings for the second quarter of fiscal 2025
Piedmont Lithium (PLL) Q2 Loss Beats 31%
Piedmont Lithium (NASDAQ:PLL), a North American lithium developer and producer, released its financial results for Q2 2025 on August 7, 2025. The key highlight was a narrower adjusted
BioAtla (BCAB) Q2 Loss Narrows 27%
BioAtla (NASDAQ:BCAB), a clinical-stage biotech developing therapies for hard-to-treat cancers, released its second quarter 2025 results on August 7, 2025. The company posted a net loss per share of
Consensus Cloud (CCSI) Q2 Revenue Rises
Consensus Cloud Solutions (NASDAQ:CCSI), a company specializing in secure digital cloud fax and healthcare data interoperability, released its second quarter results for fiscal 2025 on August 7
Occidental (OXY) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025, at 1:00 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Gogo (GOGO) Q2 Revenue Jumps 122%
Gogo (NASDAQ:GOGO), an aviation connectivity company serving business, military, and government markets, reported Q2 2025 earnings on August 7, 2025. The key news was a large year-over-year increase
CYTK Earnings Jump 3,065%
Cytokinetics (NASDAQ:CYTK), a late-stage biopharmaceutical company focused on cardiovascular disease, reported earnings for Q2 FY2025 on August 7, 2025. The headline news was a dramatic
Corvus (CRVS) Q2 Loss Beats Estimates
Corvus Pharmaceuticals (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on developing immunology and oncology therapies, released its earnings results for Q2 2025 on August 7, 2025
Rocket (RCKT) Q2 Loss Narrows 16%
Rocket Pharmaceuticals (NASDAQ:RCKT), a biotechnology company focused on gene therapies for rare and serious diseases, reported its second quarter 2025 results on August 7, 2025. The most
Sempra (SRE) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Aug. 7, 2025, at 12 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Adicet Bio (ACET) Q2 Loss Widens 3%
Adicet Bio (NASDAQ:ACET), a biotechnology company focused on gamma delta T cell therapies for autoimmune diseases and cancer, reported its second quarter 2025 earnings on August 7, 2025. No revenue
SCPH Revenue Up 99%
scPharmaceuticals (NASDAQ:SCPH), a commercial-stage pharmaceutical company focused on subcutaneous drug delivery for heart failure and chronic kidney disease patients, delivered its second quarter
Bright Mountain (BMTM) Q2 Revenue Up 18%
Bright Mountain Media (OTC:BMTM), a digital advertising and consumer insights platform, released its financial results for the second quarter of fiscal 2025 on August 7, 2025. The company reported
Fortuna (FSM) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025, at 12 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Innovative Industrial (IIPR) Earnings Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025, at 12 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Pennant (PNTG) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, Aug. 7, 2025, at 12 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
SandRidge Energy (SD) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025, at 2 p.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Why Dutch Bros Stock Skyrocketed on Thursday
Shares of Dutch Bros (NYSE: BROS) roared out of the gate on Thursday, spiking as much as 24.2%. As of 11:37 a.m. ET, the stock was still up 18.5%.
The catalyst that sent the stock soaring today was
Ecovyst (ECVT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, August 7, 2025, at 11 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com